QVT Financial’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,375,900
| Closed | -$40.8M | – | 39 |
|
|
2023
Q4 | $40.8M | Hold |
1,375,900
| – | – | 2.31% | 4 |
|
|
2023
Q3 | $21.8M | Hold |
1,375,900
| – | – | 1.23% | 6 |
|
|
2023
Q2 | $25.9M | Hold |
1,375,900
| – | – | 1.42% | 5 |
|
|
2023
Q1 | $5.28M | Hold |
1,375,900
| – | – | 0.26% | 31 |
|
|
2022
Q4 | $6.82M | Hold |
1,375,900
| – | – | 0.36% | 24 |
|
|
2022
Q3 | $6.58M | Hold |
1,375,900
| – | – | 0.46% | 31 |
|
|
2022
Q2 | $6.19M | Hold |
1,375,900
| – | – | 0.39% | 34 |
|
|
2022
Q1 | $6.55M | Hold |
1,375,900
| – | – | 0.28% | 35 |
|
|
2021
Q4 | $10.2M | Hold |
1,375,900
| – | – | 0.35% | 30 |
|
|
2021
Q3 | $7.8M | Hold |
1,375,900
| – | – | 0.58% | 31 |
|
|
2021
Q2 | $9.07M | Hold |
1,375,900
| – | – | 0.6% | 27 |
|
|
2021
Q1 | $11.1M | Hold |
1,375,900
| – | – | 0.78% | 21 |
|
|
2020
Q4 | $8.88M | Hold |
1,375,900
| – | – | 0.49% | 25 |
|
|
2020
Q3 | $4.95M | Hold |
1,375,900
| – | – | 0.6% | 29 |
|
|
2020
Q2 | $6.33M | Hold |
1,375,900
| – | – | 1.08% | 27 |
|
|
2020
Q1 | $4.69M | Hold |
1,375,900
| – | – | 1.09% | 28 |
|
|
2019
Q4 | $7.02M | Hold |
1,375,900
| – | – | 1.37% | 25 |
|
|
2019
Q3 | $3.33M | Hold |
1,375,900
| – | – | 0.68% | 36 |
|
|
2019
Q2 | $2.84M | Hold |
1,375,900
| – | – | 0.6% | 33 |
|
|
2019
Q1 | $3.44M | Buy |
+1,375,900
| New | +$5.96M | 0.87% | 30 |
|
Other funds holding IMGN
QVT Financial's IMGN Position: Q1 2024 in Review
QVT Financial sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,375,900 shares — an estimated $40.8M sold.
QVT Financial first reported a position in IMGN in Q1 2019 and held it in 20 quarters. The position peaked at $40.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- QVT Financial reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- QVT Financial sold 1,375,900 Immunogen Inc shares in Q1 2024, an estimated $40.8M.
- QVT Financial first reported a position in Immunogen Inc in Q1 2019 and held it in 20 quarters.
- QVT Financial's Immunogen Inc position peaked at $40.8M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on QVT Financial's 13F filing for Q1 2024, filed 15 May 2024.